Mark Boguniewicz
0000-0002-1015-4439
4 papers found
Refreshing results…
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis
Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults
Distribution of atopic dermatitis lesions in United States adults
Missing publications? Search for publications with a matching author name.